序号 |
标题 |
次数 |
作者 |
发布时间 |
36946 |
1,2-Dioleoyl-sn-glycero-3-phosphocholine,CAS: 4235-95-4 |
60 |
axc |
2025-02-14 |
36947 |
mPEG-SA 甲氧基聚乙二醇丁二酸 |
46 |
h |
2025-02-14 |
36948 |
Boc-Pro-OMe ,CAS: 59936-29-7,淡黄色液体 |
74 |
axc |
2025-02-14 |
36949 |
mPEG-GA 甲氧基聚乙二醇戊二酸 |
56 |
h |
2025-02-14 |
36950 |
iRGD-PEG-DSPE 磷脂-聚乙二醇-iRGD |
54 |
h |
2025-02-14 |
36951 |
1,2-二棕榈酰基-SN-甘油-3-磷酸乙醇胺-N-丁二酰钠盐,186800-61-3 |
58 |
axc |
2025-02-14 |
36952 |
DSPE-PEG-iRGD 磷脂PEG多肽 |
46 |
h |
2025-02-14 |
36953 |
RGD-PEG-DSPE 磷脂PEG多肽 |
44 |
h |
2025-02-14 |
36954 |
DSPE-PEG-Alkyne,MW:3400 |
50 |
wyh |
2025-02-14 |
36955 |
1,2-二豆蔻酰-SN-甘油-3-磷酸单钠盐(DMPA),80724-31-8,磷脂酸类化合物 |
82 |
axc |
2025-02-14 |
36956 |
DSPE-PEG-OH,MW:3400 |
47 |
wyh |
2025-02-14 |
36957 |
DPPE-mPEG2000(铵盐),474922-84-4,白色或类白色粉末 |
57 |
axc |
2025-02-14 |
36958 |
DSPE-PEG-RGD 磷脂聚乙二醇多肽 |
50 |
h |
2025-02-14 |
36959 |
cRGD-PEG-DSPE 肿瘤靶向肽 |
53 |
h |
2025-02-14 |
36960 |
DSPE-PEG-PDP,MW:3400 |
49 |
wyh |
2025-02-14 |
36961 |
十三酸甘油三酯,26536-12-9,具有酯类化合物的典型化学性质 |
62 |
axc |
2025-02-14 |
36962 |
DSPE-PEG-RGD 脂质体修饰靶向穿膜肽RGD |
46 |
h |
2025-02-14 |
36963 |
NGR-PEG-DSPE 磷脂PEG肿瘤新生血管靶向肽 |
47 |
h |
2025-02-14 |
36964 |
DSPE-PEG-Estrogen,MW:3400 |
59 |
wyh |
2025-02-14 |
36965 |
(S)-1,2-二棕榈酰-sn-甘油醇(DPG),30334-71-5 |
66 |
axc |
2025-02-14 |
36966 |
DSPE-PEG-TAT 磷脂-聚乙二醇-穿膜肽TAT |
48 |
h |
2025-02-14 |
36967 |
DSPE-PEG-TAT 磷脂-聚乙二醇-穿膜肽TAT |
52 |
h |
2025-02-14 |
36968 |
1-硬脂酰-2-油酰-sn-甘油-3-磷酸单钠盐(SOPA-Na),384833-24-3,磷脂类化合物 |
54 |
axc |
2025-02-14 |
36969 |
DSPE-PEG-anisamide,MW:3400 |
49 |
wyh |
2025-02-14 |
36970 |
DSPE-PEG-Pemetrexed,MW:3400 |
64 |
wyh |
2025-02-14 |
36971 |
1-棕榈酰-2-亚油酰-sn-甘油-3-磷脂酰乙醇胺(PLinPE),26662-95-3 |
85 |
axc |
2025-02-14 |
36972 |
(S)-1,2-二硬脂酰-sn-甘油醇,10567-21-2 特点 |
89 |
axc |
2025-02-14 |
36973 |
DSPE-PEG-Raltitrexed,MW:3400 |
72 |
wyh |
2025-02-14 |
36974 |
2-(2-(2-氨基乙氧基)乙氧基)乙酸盐酸盐(AEEA盐酸盐),cas:134979-01-4 |
78 |
axc |
2025-02-14 |
36975 |
DSPE-PEG-Metronidazole,,MW:3400 |
63 |
wyh |
2025-02-14 |
36976 |
甲氧基聚乙二醇缩环氧丙烷,特点 |
63 |
axc |
2025-02-14 |
36977 |
DSPE-PEG-Ciprofloxacin,MW:3400 |
51 |
wyh |
2025-02-14 |
36978 |
PTP-PEG-DSPE 磷脂PEG胰腺癌靶向肽PTP |
57 |
h |
2025-02-14 |
36979 |
DSPE-PEG-cisplatin,MW:3400 |
45 |
wyh |
2025-02-14 |
36980 |
TH-PEG-DSPE 响应性穿膜肽TH-PEG-磷脂 |
51 |
h |
2025-02-14 |
36981 |
DSPE-PEG-DOX,MW:3400 |
59 |
wyh |
2025-02-14 |
36982 |
DSPE-PEG-Paclitaxel,MW:3400 |
49 |
wyh |
2025-02-14 |
36983 |
DSPE-PEG-PTP(KTLLPTP) 胰腺癌靶向肽 |
69 |
h |
2025-02-14 |
36984 |
DSPE-PEG-MTX,MW:3400 |
49 |
wyh |
2025-02-14 |
36985 |
DSPE-PEG-Dopamine,MW:3400 |
48 |
wyh |
2025-02-14 |
36986 |
PLGA-PEG-Biotin |
44 |
h |
2025-02-14 |
36987 |
DSPE-PEG-Comarin,MW:3400 |
54 |
wyh |
2025-02-14 |
36988 |
1,2-二硬脂酰-rac-甘油-3-甲氧基聚乙二醇5000,308805-39-2(PEG5000),具有双亲性结构的化合物 |
69 |
axc |
2025-02-14 |
36989 |
DSPE-PEG-Cy3,MW:3400 |
62 |
wyh |
2025-02-14 |
36990 |
PLGA-PEG-Biotin,Biotin-PEG-PLGA |
75 |
h |
2025-02-14 |